Historical record - last NADAC effective date: 2/20/2019
Product Information
GLYBURID-METFORMIN 1.25-250 MG is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0466 per EA under NDC 57237002305. Its NADAC has been published 306 times since Apr 9, 2014.
FDA first approved this application on Nov 14, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1.25; 250 mg/1; mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237002305
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/20/2019
Active Ingredients
GLYBURIDE; METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077870FDA Approved
11/14/2007
TE Code
AB
On Market Since
11/14/2007
Pharmacological Classes
Price Statistics
The NADAC for GLYBURID-METFORMIN 1.25-250 MG has been published 306 times since Apr 9, 2014, and over the history we have for it it has declined 46.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0466 per EA |
|---|---|
| All-time high | $0.0908 (May 11, 2016) |
| All-time low | $0.0456 (Jan 23, 2019) |
| Median price | $0.0590 |
| Average price | $0.0625 |
| Largest weekly change | +37.5% (Jun 22, 2016) |
| Weeks tracked | 306 |
| Tracking since | Apr 9, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-46.1%
Last surveyed Feb 12, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 28% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GLYBURID-METFORMIN 1.25-250 MG?
The current National Average Drug Acquisition Cost (NADAC) for GLYBURID-METFORMIN 1.25-250 MG, manufactured by Rising Pharma Holdings Inc., is $0.0466 per EA (NDC 57237002305), effective Feb 12, 2020.
How has the price of GLYBURID-METFORMIN 1.25-250 MG changed over time?
Over the history we have for it, the NADAC for GLYBURID-METFORMIN 1.25-250 MG has declined 46.1%. It has been tracked across 306 weekly CMS publications since Apr 9, 2014.
What are the highest and lowest recorded NADAC prices for GLYBURID-METFORMIN 1.25-250 MG?
Since Apr 9, 2014, the NADAC for GLYBURID-METFORMIN 1.25-250 MG has ranged from a low of $0.0456 (Jan 23, 2019) to a high of $0.0908 (May 11, 2016), with a median of $0.0590 per EA.
Are there cheaper alternatives to GLYBURID-METFORMIN 1.25-250 MG?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLYBURID-METFORMIN 1.25-250 MG, is $0.0335 per EA — about 28% below GLYBURID-METFORMIN 1.25-250 MG.
Who manufactures GLYBURID-METFORMIN 1.25-250 MG?
GLYBURID-METFORMIN 1.25-250 MG (NDC 57237002305) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.